Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Deferasirox 180 mg film-coated tablets

Active Ingredient:
deferasirox
Company:  
Glenmark Pharmaceuticals Europe Ltd See contact details
ATC code: 
V03AC03
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials HCP Med Info
{arrow_left}
{arrow_right}

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

{pdf_link}

Important information for Healthcare Professionals

{healthcare_pro_orange} For Healthcare Professionals
minimise key adverse effects including medication errors during treatment
{pdf_link}

Important information for patients about your treatment and possible side effects

Booklet for patients that have been prescribed deferasirox. It contains important information, including how to take deferasirox the right way, why monitoring your treatment is important, and which medicines you can take while on deferasirox.
{pdf_link}

Physician’s reference checklist for Deferasirox (deferasirox) dosing and biological monitoring

{healthcare_pro_orange} For Healthcare Professionals
Document highlights important information about requirements for Deferasirox (deferasirox) dosing, dose adjustment and biological monitoring.

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Glenmark Pharmaceuticals Europe Ltd
Company image
Address
Building 2, Croxley Park, Watford, WD18 8YA
Telephone
+44 (0)1923 202 950
Fax
+44 (0)1923 251137
Medical Information Direct Line
0800 458 0383
E-mail
[email protected]
Stock Availability
+44 (0)1923 202 950
WWW
www.glenmarkpharma.com